Bank of China (03988) successfully issued 50 billion yuan in subordinated capital bonds.
China Bank (03988) announced that, approved by relevant regulatory authorities, the bank issued a total of 50 billion yuan of subordinated capital bonds with a reduced amount on the national interbank bond market on June 12, 2026, and the issuance was completed on June 16, 2026. This bond has a term of 10 years, a fixed interest rate of 1.93%, and a issuance scale of 50 billion yuan, with a redemption right for the issuer at the end of the 5th year.
Bank of China (03988) announced that, with approval from relevant regulatory authorities, the bank issued a total of 50 billion RMB in subordinated capital bonds on the national interbank bond market on June 12, 2026. The issuance was completed on June 16, 2026. The bonds have a fixed interest rate for a 10-year term, with a face value of 500 billion RMB and a coupon rate of 1.93%. The issuer has redemption rights at the end of the 5th year.
Related Articles
CSPC PHARMA (01093): The application for the listing permit of Valsartan and Amlodipine Maleate Tablets (SYH 9056 Tablets) has been accepted by the National Medical Products Administration.
REGENT PACIFIC(00575): Senstend receives a milestone approval from the National Medical Products Administration.
BEAUTYFARM MED (02373) spent 1.07 million Hong Kong dollars to repurchase 60,000 shares on June 16th.
CSPC PHARMA (01093): The application for the listing permit of Valsartan and Amlodipine Maleate Tablets (SYH 9056 Tablets) has been accepted by the National Medical Products Administration.
REGENT PACIFIC(00575): Senstend receives a milestone approval from the National Medical Products Administration.
BEAUTYFARM MED (02373) spent 1.07 million Hong Kong dollars to repurchase 60,000 shares on June 16th.
RECOMMEND
